China Pharma Holdings (CPHI) Operating Margin (2016 - 2025)
Historic Operating Margin for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to 83.06%.
- China Pharma Holdings' Operating Margin rose 155800.0% to 83.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.83%, marking a year-over-year increase of 27200.0%. This contributed to the annual value of 101.32% for FY2024, which is 620800.0% down from last year.
- Per China Pharma Holdings' latest filing, its Operating Margin stood at 83.06% for Q3 2025, which was up 155800.0% from 63.57% recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Operating Margin registered a high of 20.28% during Q1 2023, and its lowest value of 150.44% during Q2 2024.
- Its 5-year average for Operating Margin is 57.54%, with a median of 48.33% in 2022.
- In the last 5 years, China Pharma Holdings' Operating Margin tumbled by -1088800bps in 2024 and then skyrocketed by 868700bps in 2025.
- Over the past 5 years, China Pharma Holdings' Operating Margin (Quarter) stood at 22.45% in 2021, then crashed by -78bps to 40.02% in 2022, then tumbled by -38bps to 55.1% in 2023, then crashed by -91bps to 105.47% in 2024, then rose by 21bps to 83.06% in 2025.
- Its last three reported values are 83.06% in Q3 2025, 63.57% for Q2 2025, and 66.76% during Q1 2025.